CIMT Working Groups

From developing research programs to weighing in on legislative processes, CIMT is a community effort to facilitate and foster the research and clinical translation of cancer immunotherapies. CIMT currently hosts two working groups that address immunoguiding standards (CIMT Immunoguiding Program-CIP) and the regulatory environment of new immunotherapies
(CIMT Regulatory Research Group-RRG).

The CIMT Immunoguiding Program (“CIP”)

Community-driven immunoguiding


Facilitating the translation of scientific knowledge from bench to bedside.


Get the CIMT newsletter

Subscribe to CIMT newsletter